How We Think - Biopharmaceuticals

These are the posts from the How we think section that have been tagged with Biopharmaceuticals.

To see all tags used in our posts, click here.

Molecules in a particle-based vaccine for cancer therapy

Immunotherapies in oncology: the future of cancer treatment lies in combinations and partnerships

Frances Hendry | 19th May 2017

Anne Legendre reviews the scientific rationale behind immunotherapy combinations and Frances Hendry examines how partnerships, co-marketing and positioning drugs will play key roles in shaping the competitive landscape in oncology.

read more

intro-to-manufacturing-biologics-lab-science

Introduction to the manufacturing of biologics

Ditte Funding | 12th December 2016

The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the opportunities and threats they present. Associate Consultant Ditte Funding takes us through how biologics are made, what makes them unique, and what it all means for pharma companies.

read more